Morgan Stanley
CDMO

Morgan Stanley’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Morgan Stanley’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-466,631
Closed -$5.76M – 8308
2024
Q4 		$5.76M Sell
466,631
-246,069
-35% -$2.82M ﹤0.01% 3882
2024
Q3 		$8.11M Buy
712,700
+118,508
+20% +$1.19M ﹤0.01% 3591
2024
Q2 		$4.24M Sell
594,192
-793,910
-57% -$6.07M ﹤0.01% 4016
2024
Q1 		$9.3M Sell
1,388,102
-749,774
-35% -$5.16M ﹤0.01% 3405
2023
Q4 		$13.9M Buy
2,137,876
+1,111,378
+108% +$7.16M ﹤0.01% 3650
2023
Q3 		$9.69M Sell
1,026,498
-26,211
-2% -$315K ﹤0.01% 3152
2023
Q2 		$14.7M Sell
1,052,709
-23,351
-2% -$398K ﹤0.01% 2795
2023
Q1 		$20.2M Sell
1,076,060
-89,034
-8% -$1.46M ﹤0.01% 2405
2022
Q4 		$16M Buy
1,165,094
+150,101
+15% +$2.3M ﹤0.01% 2566
2022
Q3 		$19.4M Sell
1,014,993
-171,323
-14% -$3.12M ﹤0.01% 2216
2022
Q2 		$18.1M Sell
1,186,316
-46,360
-4% -$686K ﹤0.01% 2402
2022
Q1 		$25.1M Buy
1,232,676
+569,759
+86% +$11.6M ﹤0.01% 1878
2021
Q4 		$19.3M Buy
662,917
+161,149
+32% +$4.61M ﹤0.01% 2191
2021
Q3 		$10.8M Sell
501,768
-97,544
-16% -$2.35M ﹤0.01% 2799
2021
Q2 		$15.4M Buy
599,312
+357,664
+148% +$7.64M ﹤0.01% 2474
2021
Q1 		$4.41M Sell
241,648
-172,194
-42% -$2.86M ﹤0.01% 3541
2020
Q4 		$4.78M Buy
413,842
+405,202
+4,690% +$3.7M ﹤0.01% 3305
2020
Q3 		$66K Sell
8,640
-27,442
-76% -$208K ﹤0.01% 5610
2020
Q2 		$237K Buy
36,082
+24,960
+224% +$139K ﹤0.01% 4996
2020
Q1 		$57K Sell
11,122
-93,075
-89% -$563K ﹤0.01% 5421
2019
Q4 		$799K Buy
104,197
+81,885
+367% +$478K ﹤0.01% 4669
2019
Q3 		$119K Buy
22,312
+17,635
+377% +$109K ﹤0.01% 5378
2019
Q2 		$26K Sell
4,677
-8,561
-65% -$35.3K ﹤0.01% 5843
2019
Q1 		$56K Sell
13,238
-69,485
-84% -$283K ﹤0.01% 5618
2018
Q4 		$339K Sell
82,723
-3,230
-4% -$16.9K ﹤0.01% 5039
2018
Q3 		$590K Sell
85,953
-34,823
-29% -$206K ﹤0.01% 4902
2018
Q2 		$473K Buy
120,776
+108,970
+923% +$378K ﹤0.01% 5147
2018
Q1 		$34K Sell
11,806
-37,449
-76% -$116K ﹤0.01% 5991
2017
Q4 		$191K Buy
49,255
+19,998
+68% +$85.7K ﹤0.01% 5426
2017
Q3 		$92K Buy
29,257
+19,541
+201% +$73.4K ﹤0.01% 5602
2017
Q2 		$41K Sell
9,716
-51,677
-84% -$212K ﹤0.01% 5913
2017
Q1 		$281K Buy
61,393
+47,023
+327% +$158K ﹤0.01% 5146
2016
Q4 		$32K Buy
14,370
+13,163
+1,091% +$30.8K ﹤0.01% 5872
2016
Q3 		$3K Buy
1,207
+500
+71% +$1.34K ﹤0.01% 6330
2016
Q2 		$1K Sell
707
-10,173
-94% -$28.4K ﹤0.01% 6451
2016
Q1 		$32K Sell
10,880
-37,545
-78% -$201K ﹤0.01% 5775
2015
Q4 		$396K Buy
48,425
+15,976
+49% +$129K ﹤0.01% 4698
2015
Q3 		$231K Buy
32,449
+22,668
+232% +$189K ﹤0.01% 5012
2015
Q2 		$90K Buy
9,781
+2,899
+42% +$27.9K ﹤0.01% 5637
2015
Q1 		$65K Sell
6,882
-12,232
-64% -$118K ﹤0.01% 5696
2014
Q4 		$186K Buy
19,114
+12,663
+196% +$128K ﹤0.01% 5278
2014
Q3 		$62K Buy
6,451
+1,830
+40% +$20.5K ﹤0.01% 5654
2014
Q2 		$61K Sell
4,621
-17,481
-79% -$220K ﹤0.01% 5705
2014
Q1 		$294K Buy
22,102
+19,343
+701% +$255K ﹤0.01% 4901
2013
Q4 		$27K Sell
2,759
-393
-12% -$3.7K ﹤0.01% 5804
2013
Q3 		$31K Buy
+3,152
New +$31.3K ﹤0.01% 5248

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley's CDMO Position: Q1 2025 in Review

Morgan Stanley sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 466,631 shares — an estimated $5.76M sold.

Morgan Stanley first reported a position in CDMO in Q3 2013 and held it in 46 quarters. The position peaked at $25.1M in Q1 2022. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Morgan Stanley reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Morgan Stanley sold 466,631 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $5.76M.
  • Morgan Stanley first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2013 and held it in 46 quarters.
  • Morgan Stanley's Avid Bioservices, Inc. Common Stock position peaked at $25.1M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.